Stereotactic ablative radiotherapy (SABR) is a way of giving radiotherapy to precisely target certain cancers and has been available in the West Midlands for a number of years.
Find out about our 3 SABR MDTs in the West Midlands
Developing SABR services across the West Midlands
SABR is one of our key priorities for our 2026-27 work plan
Supporting SABR services across the West Midlands
We will be sharing experiences and learning from prostate SABR implementation at our showcase event on Friday 4 December.
Access the presentations and resources from our previous SABR study days:
Liver SABR
Currently, patients can only access liver SABR from one provider, University Hospitals Birmingham (UHB) NHS Foundation Trust.
During 2026-27, we are working to expand the liver SABR service provision, so that patients can access services closer to home, and to increase the overall capacity and resilience. We will initially look to roll out to University Hospitals Coventry and Warwickshire (UHCW) NHS Trust and to University Hospitals of North Midlands (UHNM) NHS Trust.
Lung SABR
All of our trusts offer lung SABR, but activity levels are quite variable across the West Midlands.
During 2026-27, we hope to understand this variation further and look at opportunities for increasing access to lung SABR for patients across the region.
Prostate SABR
NHS England formally commissioned prostate SABR in July 2026. Our trusts are at different stages in terms of implementation prostate SABR: some already offer this, whilst others will be commencing service provision shortly..
| Trust | Go live date |
| RWT | March/April 2027 |
| SaTH | November 2026 |
| UHB | June 2025 |
| UHCW | April 2025 |
| UHNM | Late 2026 |
| WAH | August 2026 |
Re-irradiation
Currently, only UHB is commissioned by NHS England for re-irradiation
Renal SABR
UHB is currently the only provider for renal SABR, although since July 2026, this has been universally commissioned by NHS England.
We hope to expand service provision across the West Midlands during 2027-28